Figure 7From: Immunological evaluation of the new stable ultrasound contrast agent LK565: a phase one clinical trial HLA-DR expression after LK565 application HLA-DR expression relative to starting value and differential cell count after LK565 application (n = 15, error bars show standard error).Back to article page